Transposagen Gets $325K Forgivable Loan from Kentucky Program | GenomeWeb
NEW YORK (GenomeWeb News) – Transposagen Biopharmaceuticals, a privately held firm making animal models of human disease for research purposes, today said that it has been approved for a $325,000 forgivable loan from the Kentucky High-Tech Investment Pool.
Lexington, Ky.-based Transposagen said that it will use the funding to purchase lab equipment and to “obtain protection” for its intellectual property.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.